Loading organizations...
Recordati focuses on the research, development, and commercialization of medicines as a global pharmaceutical company. It specializes in a diverse portfolio across various therapeutic areas, with significant emphasis on rare diseases. The company expands its offerings through internal innovation and strategic acquisitions, providing essential medications to improve patient health worldwide.
Tracing its origins back a century, the company began as a family pharmacy in Correggio, Italy. Giovanni Recordati founded the enterprise, driven by insight into pharmaceutical development. His initial venture gradually evolved, transforming a local establishment into a global pharmaceutical group committed to advancing medical solutions.
Recordati primarily serves patient populations globally, especially those with rare diseases and unmet needs. The company's vision centers on elevating human health and enhancing quality of life through effective pharmaceutical solutions. It aims to deliver a lasting, positive impact on global healthcare.
Key people at Recordati.
Recordati was founded in 1926 by Giovanni Recordati (Founder).
Key people at Recordati.
Recordati has 1 tracked investment across 1 company. The latest tracked deal is $8.0M Seed in STRM in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 7, 2026 | STRM | $8.0M Seed | Recordati | Blue BAY Capital Fund, Boehringer Ingelheim Venture Fund, Delos Capital |
Recordati was founded in 1926 by Giovanni Recordati (Founder).